Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Michael Young who wrote (4077)	6/8/2001 11:12:02 AM
From: Michael Young	Respond to of 52153

From IBD....... "Prescription drug spending likely will double by 2006, Merck-Medco forecasts. The biggest U.S. drug management firm said just over half of the increase will come on rising spending for cardiovascular and central nervous system drugs such as those for depression, pain and arthritis. The projected is fueled not by senior citizens but by baby boomers developing chronic health problems like heart disease and gastrointestinal disorders, Merck said. But many branded drugs will lose their patents in the next few years."